menu search

LPCN / Lipocine to Present at Biotech Showcase

Lipocine to Present at Biotech Showcase
Company Management Will Also Host Meetings at LifeSci Partners Corporate Access Event SALT LAKE CITY , Jan. 5, 2023 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company focused on treating Central Nervous System ("CNS") disorders by leveraging its proprietary platform to develop differentiated products, today announced that its management will present at the Biotech Showcase and host institutional investor and partnering meetings at this event and a Corporate Access Event organized by LifeSci Partners. Both in-person events will take place January 9-11, 2023, in San Francisco, California. Read More
Posted: Jan 5 2023, 08:00
Author Name: PRNewsWire
Views: 110261

LPCN News  

Lipocine to Present at the H.C. Wainwright Annual NASH Investor Conference

By PRNewsWire
October 23, 2023

Lipocine to Present at the H.C. Wainwright Annual NASH Investor Conference

SALT LAKE CITY , Oct. 23, 2023 /PRNewswire/ -- Lipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company focused on treating Central Nervous System (C more_horizontal

Lipocine to Present at Biotech Showcase

By PRNewsWire
January 5, 2023

Lipocine to Present at Biotech Showcase

Company Management Will Also Host Meetings at LifeSci Partners Corporate Access Event SALT LAKE CITY , Jan. 5, 2023 /PRNewswire/ -- Lipocine Inc. (NAS more_horizontal


Search within

Pages Search Results: